Diabetes drugs and weight loss - Mayo Clinic
2024年11月14日 · Tirzepatide (Mounjaro) is a similar kind of medicine called a dual-acting GLP-1/GIP agonist. It's also used to control blood sugar and can support weight loss. It is taken once a week by a shot. All GLP-1 agonists can help with weight loss. But the amount of weight loss depends on the type of medicine and the dose.
Agonistas del GLP-1: fármacos para la diabetes y pérdida de peso
2022年8月11日 · Hu M, et al. Effect of hemoglobin A1c reduction or weight reduction on blood pressure in glucagon-like peptide-1receptor agonist and sodium-glucose cotransporter-2 inhibitor treatment in type 2 diabetes mellitus: A meta-analysis.
ناهضات GLP-1: عقاقير مرض السكري وفقدان الوزن
Hu M, et al. Effect of hemoglobin A1c reduction or weight reduction on blood pressure in glucagon-like peptide-1receptor agonist and sodium-glucose cotransporter-2 inhibitor treatment in type 2 diabetes mellitus: A meta-analysis.
Semaglutide (subcutaneous route) - Mayo Clinic
2024年10月1日 · Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight and keep the weight off in patients with at least one weight-related medical condition.
Management of obesity within hepatology clinics - Mayo Clinic
2023年12月12日 · Glucagon-like peptide 1 (GLP-1) receptor agonists. These agents can lead to significant weight loss. According to Dr. Watt, developing a solid understanding of how the various GLP-1 receptor agonists differ from one another may help clinicians choose the most appropriate agent for an individual patient. The Hepatology article contains a ...
Semaglutide (oral route) - Mayo Clinic
2024年10月1日 · Semaglutide is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. This medicine is available only with your doctor's prescription.
GLP-1 激动剂：糖尿病药物和减重 - 妙佑医疗国际
2022年12月15日 · 医生们确实知道 glp-1 似乎有助于抑制饥饿感。这些药物也会减缓食物从胃部进入小肠的速度。因此，您可能会更快产生且更久维持饱腹感，从而吃得更少。 除了帮助控制血糖和促进减重，glp-1 和 sglt-2 抑制剂似乎还有其他显著益处。研究发现，这类药物中有些 ...
Tirzepatide (subcutaneous route) - Mayo Clinic
2024年4月1日 · Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
Yerba mate: Is it safe to drink? - Mayo Clinic
2023年2月14日 · Yerba mate. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Jan. 17, 2023. Lopes AB, et al. Urinary concentrations of polycyclic aromatic hydrocarbon metabolites in mate drinkers in Rio Grande do Sul, Brazil.
Diagnosis and management of patients with gastroparesis
2022年1月25日 · Other conditions and factors associated with gastroparesis include type 1 and type 2 diabetes mellitus, medications that impair gastric emptying (most notably opioids, GLP-1 agonists used for diabetes and tricyclic antidepressants at high doses), neurological disorders, and autoimmune disorders.